Perbedaan Organon Pharma Indonesia Tbk. dan Vastland Indonesia Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Vastland Indonesia Tbk. diperdagangkan di Rp113 (kapitalisasi pasar 336,13 M, volume 24 jam 3,61 jt). Perbedaan utamanya: Vastland Indonesia Tbk. jauh lebih besar — sekitar 3,2× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | VAST | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 336,13 M |
Volume | — | 3,61 jt |
Lot | — | 36,15 rb |
Perputaran | — | 405,24 jt |
Harga Rata-rata | — | 112,11 |
Nilai Transaksi | — | 405,24 jt |
Harga Ekuilibrium Indikatif | — | 113 |
Volume Ekuilibrium Indikatif | — | 1 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →PT Vastland Indonesia Tbk (the Company) was established based on Deed No. 16 dated 21 February 2011 from Adrian Djuani, S.H., Notary in Jakarta. The Companys start its commercial operation on 2012.
Selengkapnya di halaman VAST →